People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kazia Therapeutics Ltd | — | Biotechnology | Series C | $61.4M | $286.5M | 2023 |
| CoreTrace Corp | — | Other Technology | Series A | $15.2M | $99.9M | 2009 |
Steven Coffey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven Coffey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ray Rothrock | 1 | 10 |
| CRAIG ROBINSON | 1 | 3 |
| John Friend | 1 | 3 |
| Derek Hutson | 1 | 2 |
| Steve Coffey | 1 | 2 |
| Toney Jennings | 1 | 2 |
| Robert Apple | 1 | 2 |
| Tim Wall | 1 | 2 |
| JT Keating | 1 | 2 |
| Daniel M. Teal | 1 | 1 |
| Karen Krumeich | 1 | 1 |
| Ray M. Rothrock | 1 | 1 |
| Robert M. Huffman | 1 | 1 |
| Elissa Hansen | 1 | 1 |
| James Reiss | 1 | 1 |
| Robert Huffman | 1 | 1 |
| Joe Sirrianni | 1 | 1 |
| Daniel Teal | 1 | 1 |
| Richard Teal | 1 | 1 |
| James M. Reiss | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.